ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Influence Of HLA-DR Mismatches On Long Term Outcomes Following Heart Transplantation

A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX

Meeting: 2019 American Transplant Congress

Abstract number: B99

Keywords: Heart transplant patients, HLA matching, HLA-DR antigens, Survival

Session Information

Date: Sunday, June 2, 2019

Session Name: Poster Session B: Heart and VADs: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Impact of HLA Mismatches and Cytomegalovirus Seropositivity on Outcomes Following Heart Transplantation
  • High Frequency of HLA-DQ De Novo Donor Specific Antibodies is Independent of the Number of Mismatches in Heart Transplant

*Purpose: In the field of kidney transplantation, there is strong support for the beneficial effect of minimizing donor-recipient HLA incompatibility, and HLA-DR matching in particular contributes the most to graft survival and function. However, there are conflicting reports on the effect of donor-recipient HLA-DR matching on outcomes in heart transplantation. A few studies have shown HLA-DR matching reduces the incidence of graft rejection within the first year and increases short term graft survival. It is not known if HLA-DR matching impacts long term outcomes. We sought to analyze the effect of HLA-DR mismatches on long term survival, and also explain possible mechanisms for its impact on survival.

*Methods: All adult heart transplantations performed at our institution from 2000 to 2010 were retrospectively reviewed. Multi-organ transplant recipients, patients who expired within the first year after transplantation and those with missing data were excluded. Patients were grouped according to the number of HLA-DR mismatches: 0, 1 or 2. We analyzed allograft function [using the most recent ejection fraction (EF)], development of angiographically significant (ISHLT grade >2) cardiac allograft vasculopathy (CAV) and survival in these groups. ANOVA was used for analysis. Kaplan-Meier survival curves were generated. P value <0.05 considered significant.

*Results: A total of 172 heart transplant recipients were included in the analysis. HLA-DR mismatch status was as follows: 9 (5.2%) had 0, 63 (36.6%) had 1, and 100 (58.1%) had 2 mismatches. There were more men in the group with 2 mismatches (82% vs 74.6% vs 66.7%, P<0.0001).There was no difference in the development of significant CAV in the three groups (33.3% vs 17% vs 12%, P=0.23). There was no difference in the severity of CAV (mean ISHLT grade 1.11+1 vs 0.7+1 vs 0.57+0.8, P=0.23). Mean EF was also no different between the three groups (63.9+12.9% vs 68+6.4% vs 68.5+5.5%, P=0.12). Survival to 10 years was similar in the three groups (77.8% vs 68.1% vs 58.4%, P=0.44).

*Conclusions: In our cohort, HLA-DR mismatches did not affect graft function, as assessed by EF, development and severity of angiographically significant CAV. There was no impact on long term patient survival. Therefore, HLA-DR matching prior to heart transplantation may not be justified given the increased cost, logistical burden of HLA matching and the longer cold‐ischemic times that may result from reliance on tissue typing.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Singhvi A, Araujo-Gutierrez R, Park MH, Bhimaraj A, Trachtenberg BH, Hussain I, Guha A. Influence Of HLA-DR Mismatches On Long Term Outcomes Following Heart Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/influence-of-hla-dr-mismatches-on-long-term-outcomes-following-heart-transplantation/. Accessed February 27, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.